Gentian Diagnostics ASA reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was NOK 34.18 million compared to NOK 30.1 million a year ago. Revenue was NOK 36.16 million compared to NOK 32.88 million a year ago. Net income was NOK 0.908 million compared to net loss of NOK 2.99 million a year ago. Basic earnings per share from continuing operations was NOK 0.06 compared to basic loss per share from continuing operations of NOK 0.19 a year ago.
For the six months, sales was NOK 65.62 million compared to NOK 50.65 million a year ago. Revenue was NOK 69.76 million compared to NOK 55.97 million a year ago. Net income was NOK 0.251 million compared to net loss of NOK 9.62 million a year ago.